What's Happening?
Sonex Health has announced results from the largest-ever U.S. study on ultrasound-guided carpal tunnel release (UGCTR), demonstrating its safety and efficacy. The study, published in the Journal of Hand Surgery Global Online, involved 887 patients and 1,082
hands treated across 22 sites. The findings show rapid improvement in symptoms and high patient satisfaction, with a median recovery time of three days. UGCTR allows for simultaneous treatment of both hands and is performed using local anesthesia, reducing recovery time and healthcare costs. The study aims to compare UGCTR with other procedural approaches like endoscopic and open carpal tunnel release.
Why It's Important?
The study's findings are significant for patients suffering from carpal tunnel syndrome (CTS), as UGCTR offers a less invasive and quicker recovery option compared to traditional methods. This can reduce the financial impact of time away from work, benefiting both patients and employers. For healthcare providers, UGCTR presents a cost-effective treatment option that can lower overall healthcare expenditures related to CTS, which costs over $2 billion annually in the U.S. The study reinforces Sonex Health's commitment to advancing ultrasound-guided solutions, potentially influencing treatment standards and practices in orthopedic surgery.
